Multicenter phase II study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PII).

Masato Kondo,Hironaga Satake,Motoko Mizumoto,Akira Miki,Takanori Watanabe,Norimitsu Tanaka,Kenro Hirata,Hiroaki Tanioka,Yoshihiro Okita,Takahisa Kyogoku,Mitsutoshi Tatsumi,Koreatsu Matoba,Shinichi Adachi,Satoshi Kaihara,Hisateru Yasui,Akihito Tsuji

Multicenter phase II study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PII).

2020

Masato Kondo
Hironaga Satake
Motoko Mizumoto
Akira Miki
Takanori Watanabe
Norimitsu Tanaka
Kenro Hirata
Hiroaki Tanioka
Yoshihiro Okita
Takahisa Kyogoku
Mitsutoshi Tatsumi
Koreatsu Matoba
Shinichi Adachi
Satoshi Kaihara
Hisateru Yasui
Akihito Tsuji

399Background: Prognosis for locally advanced gastric cancer (LAGC), such as clinical T4 disease, bulky nodal metastases, type 4 and large type 3 gastric cancer, was not satisfactory even by D2 gas...

Keywords:

Cancer
Oxaliplatin
Phases of clinical research
Internal medicine
Chemotherapy
Oncology
Medicine
Pathology
locally advanced
Disease

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations